Clinical Trial Update: PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) [Phase 2]

View source ↗

Summary

Phase 2 trial updating palbociclib rechallenge in hormone receptor–positive/HER2-negative advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer, Advanced Breast Cancer | Phase 2 | Status: COMPLETED